top of page
Medical Checkup

MIST

Trial Enrolment Status

OPEN

Disease Under Study

Progressive Pulmonary Fibrosis

Duration

1 Year

About the Trial

A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.

Mechanism of Action:

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Asvini Kulasingham, RRT

bottom of page